Non-invasive monitoring technology developer Masimo (NSDQ:MASI) announced that it plans to acquire German ventilation company TNI Medical for an undisclosed amount. Irvine, Calif.-based Masimo pulled the trigger on the acquisition after it disclosed an investment in August 2019 that included an exclusive option to purchase Würzburg, Germany-based TNI. Masimo expects to close the deal in the […]
Masimo
Masimo gains FDA clearance for new respiration rate measurement system
Masimo (NSDQ:MASI) said today that the FDA has granted 510(k) clearance to its continuous RRp (respiration rate from the photoplethysmograph) monitoring of adult and pediatric patients with Rad-97, Radical-7, and Radius-7 Pulse CO-Oximeters. With this clearance, both continuous and spot-check RRp are now available in the U.S., supported in a variety of pulse oximetry sensors and […]
Masimo claims Apple infringed 10 of its health-monitoring patents
Patient-monitoring company Masimo (NSDQ:MASI) and spinoff company Cercacor filed suit yesterday accusing Apple (NSDQ:AAPL) of poaching its employees and infringing 10 of its patents to improve the health monitoring functions of the Apple Watch. The lawsuit, filed in federal court in California, claims that in 2013, Apple contacted Masimo and asked to meet regarding a […]
Masimo’s improved pulse oximetry tech now available to all U.S. newborns
Masimo (NSDQ:MASI) has won FDA clearance for pulse oximetry sensors with improved oxygen saturation accuracy specifications for newborns over 3 kg in weight. Masimo touted significantly improved performance specifications for the RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry. The improved specs were already available for babies under 3 kg, so […]
Masimo touts study on remote monitoring for desaturation and bradypnea
Masimo (NSDQ:MASI) announced today that its study of the Masimo Patient SafetyNet and rainbow acoustic monitoring (RAM) with RRa revealed that use of monitoring systems might provide a safety net for postoperative patients. Irvine, Calif.-based Masimo’s Patient SafetyNet is a supplemental remote monitoring patient surveillance and clinician notification system designed to work with Masimo and third-party […]
Masimo shares drop after bottom-line slide, company’s Radius Capnography wins CE Mark
Masimo (NSDQ:MASI) shares are down today after a slide on third-quarter profits, despite an increase in sales revenue. Irvine, Calif.-based Masimo posted profits of $49.1 million, or 86¢ per share, on sales of $228.9 million for the three months ended Sept. 30, for a bottom-line slide of -14.1% on revenue growth of 13.6%. Adjusted to exclude […]
Masimo wins expanded clearance for O3 oximetry device
Masimo (NSDQ:MASI) said today that its O3 regional oximetry device has been cleared for three additional indices — delta cHb, delta HHb, and delta O2Hb. These indices provide clinicians with greater visibility into changes in the underlying oxyhemoglobin and deoxyhemoglobin components used to calculate cerebral oxygen saturation, or rSO2, the Irvine, Calif.-based company said. The […]
Masimo gets in on Germany’s TNI Medical
Masimo (NSDQ:MASI) yesterday revealed an unspecified investment in Germany’s TNI Medical and its respiratory aid technology. Würzburg-based TNI developed the SoftFlow technology to deliver high-flow, warmed and humidified respiratory gases to pulmonary disease patients. It’s designed to provide room air or a mix of room air and oxygen without pneumatic systems, Masimo said. “The innovative products […]
Masimo lands CE Mark for infant hemoglobin monitor
Masimo (NSDQ:MASI) said it has won the CE Mark for a noninvasive and continuous hemoglobin monitor for newborn and infant patients weighing less than 3 kg (6.61 lbs.). SpHb uses the company’s Rainbow sensors, which allow clinicians to simultaneously measure multiple additional noninvasive parameters alongside SpHb, including oxygen saturation (SpO2) and methemoglobin (SpMet). Current […]
Masimo Q2 results exceed expectations
Masimo (NSDQ:MASI) announced second-quarter results today that beat The Street, raising its guidance for the rest of the year. The Irvine, Calif.–based patient monitoring technology company reported profits of $44.9 million, or $0.79 per share, on sales of $229.7 million for the three months ended June 29, with net income up 2.4% and sales increasing 13.6% compared […]
Masimo wins FDA clearance for neonatal O3 regional oximetry indication
Masimo (NSDQ:MASI) said today that it won FDA clearance for use of its O3 Regional Oximetry system with neonatal and infant patients. The Irvine, Calif.-based company’s technology uses near-infrared spectroscopy to assess the regional hemoglobin oxygen saturation of blood on both sides of the brain. The O3 sensors are now available in sizes to fit adult, […]
